Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma
A decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.
Read More
US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes Mellitus
Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.
Read More